Volume 64, Issue 4, Pages (October 2003)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Melamine toxicity: one more culprit in calcium kidney lithiasis

Volume 84, Issue 2, Pages (August 2013)

Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction

Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh Kidney International

Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole

Viper venom for diabetic nephropathy

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh Kidney International

Membranous nephropathy: When and how to treat

Viper venom for diabetic nephropathy

Kidney transplantation in a low-resource setting: Nigeria experience

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Burden of chronic kidney disease: North Africa

Francesco Paolo Schena Kidney International

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Volume 94, Issue 3, Pages (September 2018)

Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency Fiona E. Mackie, Timothy W. Meyer,

End-stage renal disease in living kidney donors

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Anemia as a risk factor for chronic kidney disease

Volume 84, Issue 1, Pages (July 2013)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Survival advantage in Asian American end-stage renal disease patients1

Volume 70, Issue 11, Pages (December 2006)

Gary C.W. Chan, Sydney C.W. Tang Kidney International

Renal risk scores: Progress and prospects

Volume 87, Issue 2, Pages (February 2015)

Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension A. Davenport, C. Cox, R. Thuraisingham Kidney.

Volume 64, Issue 4, Pages (October 2003)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Melamine toxicity: one more culprit in calcium kidney lithiasis

Fructose intake as a risk factor for kidney stone disease

Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect? Areef Ishani, Charles A. Herzog,

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Elevated risk of stroke among patients with end-stage renal disease

Volume 87, Issue 1, Pages (January 2015)

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Volume 73, Issue 7, Pages (April 2008)

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Prehypertension: is it relevant for nephrologists?

Volume 67, Issue 5, Pages (May 2005)

E.A. Friedman, A.L. Friedman, P. Eggers Kidney International

Volume 54, Issue 2, Pages (August 1998)

Peritoneal dialysis in Mexico

Volume 73, Issue 5, Pages (March 2008)

Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.

Low triiodothyronine and survival in end-stage renal disease

Does equal care give equal outcomes?

Volume 80, Issue 10, Pages (November 2011)

Volume 64, Issue 4, Pages (October 2003)

Is complement a target for therapy in renal disease?

Arya M. Sharma, Joachim Beige, Armin Distler Kidney International

Volume 70, Issue 10, Pages (November 2006)

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Ronen Levi, Justin Silver Kidney International

Antonio Piccoli, Luana Pillon Kidney International

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 64, Issue 4, Pages 1445-1449 (October 2003) Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan Takeshi Usami, Naoyuki Nakao, Michio Fukuda, Oki Takeuchi, Yoshinobu Kamiya, Atsuhiro Yoshida, Genjiro Kimura Kidney International Volume 64, Issue 4, Pages 1445-1449 (October 2003) DOI: 10.1046/j.1523-1755.2003.00221.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Relationships of the sums of total antihypertensive drugs, angiotensin-converting enzyme (ACE) inhibitors and calcium antagonists prescribed in money basis corrected for population in each region with the annual incidence of end-stage renal disease (ESRD) in corresponding regions. The number of observations were 66, because the 11 regions were multiplied by 6 years. The sum of antihypertensive drugs was represented in Japanese yen per person per year. Kidney International 2003 64, 1445-1449DOI: (10.1046/j.1523-1755.2003.00221.x) Copyright © 2003 International Society of Nephrology Terms and Conditions